About the job
At Alumis Inc., we are dedicated to revolutionizing the treatment of autoimmune diseases through precision medicine. Despite advancements in treatment over the past two decades, many patients with immunologic conditions still experience significant challenges. Our mission is to fundamentally improve outcomes for these patients.
Position Summary
We are actively seeking a highly qualified Senior or Executive Medical Director to spearhead the clinical development strategy for Phase 1 and Phase 2 trials assessing envudeucitinib and A-005, targeting new indications for the expansion of our innovative pipeline. This pivotal role will not only shape our clinical development portfolio from indication selection to proof-of-concept studies but will also establish you as a vital scientific leader collaborating with internal teams, regulatory bodies, and the broader medical community.
